Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Angela Testi
Vaccinating Italian Infants With a New Multicomponent Vaccine (Bexsero®) Against Meningococcal B Disease: A Cost-Effectiveness Analysis
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Related publications
News on Vaccines Against Meningococcal Disease. Vaccine Bexsero
Hygiena
Environmental
Public Health
Occupational Health
Potential Benefits of Using a Multicomponent Vaccine for Prevention of Serogroup B Meningococcal Disease
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
The New Multicomponent Vaccine Against Meningococcal Serogroup B, 4CMenB: Immunological, Functional and Structural Characterization of the Antigens
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Pin103 - A Systematic Review: Cost-Effectiveness of Vaccination With New Meningococcal Serogroup B Vaccines
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Should College Students Be Vaccinated Against Meningococcal Disease? A Cost-Benefit Analysis.
American Journal of Public Health
Environmental
Public Health
Occupational Health
A Critical Review of Cost-Effectiveness Analyses of Vaccinating Males Against Human Papillomavirus
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences With Other European Countries
PLoS ONE
Multidisciplinary
Predicted Strain Coverage of a Meningococcal Multicomponent Vaccine (4CMenB) in Portugal
PLoS ONE
Multidisciplinary
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds With the 13-Valent Pneumococcal Conjugate Vaccine in England
PLoS ONE
Multidisciplinary
